Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Find a Tender Service (FTS) |
| Notice Type: | Pipeline / planning |
| Buyer: | Healthcare Quality Improvement Partnership Ltd |
| Main Category: | Services |
| Procurement Method: | — |
| Tender Status: | Planning |
| Estimated Value (ex. VAT): | £28,400,000 |
| Estimated Value (inc. VAT): | £34,080,000 |
| Release Date: | 15 May 2026 |
| Application Deadline: | 4 June 2026 |
| Contract Start Date: | 31 July 2027 (Estimated) |
| Contract End Date: | 31 July 2032 (Estimated) |
| Contract Duration: | 5.1 years |
| Procurement ID (OCID): | ocds-h6vhtk-0699c3 |
| Notice Reference: | 044813-2026 |
Ready to bid on this contract?
BidWriter AI writes your tender response in minutes — import this contract in one click.
View Original Notice
Access the full notice on the official portal
The contract is expected to initially be delivered for a period of 5 years, at a maximum total budget of up to £16,080,000 including VAT and £13,400,000 GBP excluding VAT. Bids exceeding this limit will be rejected. There is potential to extend the contract for up to two additional years as well as the option to include other aspirational measures (which will be defined in the service specification) meaning the ceiling value has the potential to be higher. Due to the unknowns in advance of holding the premarket engagement session, it is currently expected that the extension value will be a 2 year pro rata of the core 5 year funding, estimated at £5,360,000 excluding VAT. This proposed extension value may also include pro rata funding of any additional aspirational measures invoked in the first 5 years of the contract. For example: If an aspirational annual requirement costing £500,000 per year is invoked in year 5, then the extension funding (if the aspirational measure is continued) will be the above figures plus the additional £500,000 per year. Further to this funding, the final specification will contain a list of aspirational measures which will be expected to be modified into the contract should the need and funding become available. The aspirational intent value, excluding the potential 2 year extension, is unknown at point of drafting this notice, so, an estimated value of £15,000,000 excluding VAT is applied to form the maximum total estimated value AT POINT OF DRAFTING THIS NOTICE. This aspirational intent has the potential to be invoked fully, partially, or not at all, and the Authority cannot guarantee that the successful supplier will be required to do any of the aspirational measures that will be listed in the final specification. The Healthcare Quality Improvement Partnership (HQIP) is seeking to procure the following services for the National Joint Registry (NJR). •NJR data management, solutions, statistical analysis and reporting, and (optional) associated services HQIP is not only looking for organisations to provide these services but also to partner with organisations that can demonstrate the following characteristics: •Strategic and solution orientated •Proactive, responsive and flexible •Ability to add value •Committed to continual improvement •Communicative and effective team player •Innovative Joint replacements have become common and highly successful operations that bring many patients improved mobility and relief from pain. Thousands of such operations take place in the UK every year. A wide range of implants can be used in joint replacement operations and the NJR helps to monitor the performance of these implants and the effectiveness of different types of surgery; improving clinical standards and benefiting patients, clinicians and the orthopaedic industry. The NJR was set up in April 2002 by the Department of Health (DH) and Welsh Government following a National Audit Office report into a failing ‘3M’ hip implant. From 1 April 2008, hosting arrangements for the NJR were transferred from the DH to HQIP. The NJR has collected hip and knee replacement data since April 2003, ankle replacement data since April 2010 and data for elbow and shoulder replacements since April 2012. The DH provided the initial start-up funding for the NJR. However, the system is now self-financing through a subscription charge on each ‘eligible’ hip, knee, ankle, elbow and shoulder implant which is payable by NHS Trusts (England), Health and Social Care Trusts (Northern Ireland), Local Health Boards (Wales) and independent (private) healthcare providers. The cost to the NHS was reduced in 2014 through a contributory financial subscription arrangement with the orthopaedic device industry whereby an annual subscription is charged for provision of the NJR Supplier Feedback service and other bespoke reporting. Since April 2014, the NJR subscription has been invoiced annually and the income managed in a dedicated fund at HQIP, governed by the NJR Board (NJRB). The purpose of the National Joint Registry, which covers England, Wales, Northern Ireland, the Isle of Man, the States of Guernsey and the Channel Islands, is to collect high quality and relevant data about joint replacement surgery in order to provide an early warning of issues relating to patient safety. In a continuous drive to improve the quality of outcomes and ensure the quality and cost-effectiveness of joint replacement surgery, the NJR will monitor and report on outcomes, and support and enable related research. The NJR’s strategic goals are to: •Monitor in real time the outcomes achieved by brand of prosthesis, hospital and surgeon, and highlight where these fall below an expected performance in order to allow prompt investigation and to support follow-up action. •Inform patients, clinicians, providers and commissioners of healthcare, regulators and implant suppliers of the outcomes achieved in joint replacement surgery. •Evidence variations in outcome achieved across surgical practice in order to inform best practice. •Enhance patient awareness of joint replacement outcomes to better inform patient choice and patients' quality of experience through engagement. •Support evidence-based purchasing of joint replacement implants for healthcare providers to support quality and cost effectiveness. •Support suppliers in the routine post-market surveillance of implants and provide information to clinicians, patients, hospital management and the regulatory authorities. Current Expectations - To be Defined Core service provision is expected to include: •Data systems and ingestion •Data processing and cleaning •Dynamic reporting and dashboards •Supplier feedback •Annual report statistical outputs •Outlier detection, reporting and analysis •PROMs and PREMs collection •Service desk and operational support Further details of the existing programme can be found at: https://www.njrcentre.org.uk/ For more information about this opportunity, please visit the eSourcing portal at: https://www.delta-esourcing.com/tenders/UK-UK-London:-Health-services./7449M9X8XA To respond to this opportunity, please click here: https://www.delta-esourcing.com/respond/7449M9X8XA
Published contracts in the last 12 months
23
total contracts
£196.3m
total value
£9,346,883
average contract size
Typical categories
National Early Inflammatory Autoimmune Diseases Audit
Healthcare Quality Improvement Partnership Ltd · WAC-599174
National Joint Registry - Data Management, Solutions, Statistical Analysis, Reporting & Associated Services
Healthcare Quality Improvement Partnership Ltd · WAC-597383
National Cancer Audit Collaborating Centre
Healthcare Quality Improvement Partnership Ltd · WAC-583845
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Application Deadline
4 June 2026
15 days left
Estimated Value
£28,400,000
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →